Ethical Considerations Related to Return of Results from Genomic Medicine Projects: The eMERGE Network (Phase III) Experience

Robyn Fossey(Mayo Clinic), Iftikhar J. Kullo(Medical College of Wisconsin), Sharon Aufox(Northwestern University), Erin Winkler(Mayo Clinic), Wendy K. Chung(Oregon Health & Science University), Richard R. Sharp(Mayo Clinic in Florida), Maureen E. Smith(Northwestern University), Beth L. Cobb, Janet L. Williams(Geisinger Health System), Lynn Pais(MACOM (United States)), Mary Stroud(Vanderbilt University Medical Center), Jordan W. Smoller(Massachusetts General Hospital), Joel E. Pacyna(Mayo Clinic in Florida), Margaret Harr(Children's Hospital of Philadelphia), Bahram Namjou‐Khales(Cincinnati Children's Hospital Medical Center), Alexander Fedotov(Columbia University), Melanie F. Myers(Cincinnati Children's Hospital Medical Center), Gail P. Jarvik(University of Washington Medical Center), John J. Connolly(Children's Hospital of Philadelphia), Georgia L. Wiesner(The University of Western Australia), Julia Wynn(ATUM (United States)), Hila Milo Rasouly(Columbia University Irving Medical Center), Ali G. Gharavi(Columbia University), Cynthia A. Prows(Cincinnati Children's Hospital Medical Center), Aaron Scrol(Kaiser Permanente Washington Health Research Institute), Janet E. Olson(Cornell University), David C. Kochan(Mayo Clinic), Stephen N. Thibodeau(Mayo Clinic in Arizona), Rongling Li(University of Tennessee Health Science Center), Nancy Leslie(Cincinnati Children's Hospital Medical Center), Ingrid A. Holm(Boston Children's Hospital), Meckenzie Behr(Children's Hospital of Philadelphia), Kathleen A. Leppig(Group Health Cooperative)
Journal of Personalized Medicine
January 3, 2018
Cited by 54


Related Papers